Ahmad Alenezi: Harrison.ai Secured Its 13th FDA Clearance, And This One Is a Literal Life-Saver
Ahmad Alenezi, Nuclear Medicine Technology Specialist, Assistant Professor at Kuwait University, shared on LinkedIn:
”Big news for the stroke care community!
Harrison.ai just secured its 13th FDA clearance, and this one is a literal life-saver.
They have developed the first AI cleared to triage acute ischemic stroke (tissue injury) on a patient’s very first non-contrast CT scan.
Why this matters?:
In stroke care, ‘time is brain.’
Traditionally, AI needed a second, more complex scan (CTA) to flag a blockage.
By catching signs of injury on the initial ER scan, we’re cutting down the ‘door-to-needle’ time when every second counts toward a patient’s recovery.
This isn’t just about faster tech, it’s about getting clinicians the right data earlier to prevent permanent disability.
Huge win for the team and a massive step forward for emergency radiology.
Those milestones and developments necessitate the integration of AI medical education in our syllabus.”
Stay updated with Hemostasis Today.
-
Aug 21, 2026, 12:42Moustafa Abdou: Diagnosis and Management of Pyruvate Kinase Deficiency
-
Aug 21, 2026, 12:38Luluva Ghadiyali: Modern Approaches to Aplastic Anemia
-
Aug 21, 2026, 12:34Kellie Machlus: Animal Models Driving Progress in Thrombosis Research
-
Aug 21, 2026, 12:08Amy Allen Whitfield: Helping to Proceed Bleeding Disorders Care
-
Aug 21, 2026, 11:53Jan Terje Andersen: Harnessing Placental Biology for Therapeutic Engineering
-
Aug 21, 2026, 11:02Severe ITP, Critical Bleeding, and the Challenge of Platelet Testing – RPTH Journal
-
Aug 21, 2026, 10:46Arwa Z. Al-Riyami: Looking Ahead to ISBT Muscat 2029
-
Aug 21, 2026, 10:42Janine Mothershed: What Is Romiplostim and How Does It Work in Immune Thrombocytopenia?
-
Aug 21, 2026, 10:33Omar Alkharabsheh: Excited to Build the Future of Hematologic Malignancy Care in Central Florida